Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-17 Sale | 2026-03-18 5:52 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,956 | $3.39 | $26,971 | 1,180,318 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat CEO and President | 28,298 | $3.3451 | $94,660 | 2,262,085 (Direct) | View |
| 2026-03-03 Sale | 2026-03-04 4:38 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 170,000 | $3.46 | $588,200 | 6,259,863 (Direct) | View |
| 2026-02-19 Sale | 2026-02-19 7:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $3.46 | $138,400 | 9,491,893 (Indirect Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 13,426 | $3.08 | $41,352 | 1,195,349 (Direct) | View |
| 2026-02-04 Sale | 2026-02-06 5:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $4.12 | $164,800 | 9,559,158 (Indirect Direct) | View |
| 2026-02-03 Sale | 2026-02-06 5:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 220,000 | $4.2 | $924,000 | 6,429,863 (Direct) | View |
| 2026-01-20 Sale | 2026-01-22 7:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $4.47 | $178,800 | 9,579,176 (Indirect Direct) | View |
| 2026-01-06 Sale | 2026-01-08 5:01 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 220,000 | $4.36 | $959,200 | 6,649,863 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 5:04 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $4.25 | $170,000 | 9,619,176 (Indirect Direct) | View |
| 2025-12-29 Sale | 2025-12-30 7:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 21,383 | $4.18 | $89,381 | 761,550 (Direct) | View |
| 2025-12-22 Sale | 2025-12-29 5:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 124,403 | $4.4098 | $548,592 | 2,195,156 (Direct) | View |
| 2025-12-19 Sale | 2025-12-19 5:04 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.5 | $180,000 | 9,679,176 (Indirect Direct) | View |
| 2025-12-04 Sale | 2025-12-05 7:20 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.63 | $185,200 | 9,719,176 (Indirect Direct) | View |
| 2025-12-02 Sale | 2025-12-04 4:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 220,000 | $4.37 | $961,400 | 6,869,863 (Direct) | View |
| 2025-11-19 Sale | 2025-11-19 7:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $4.16 | $166,400 | 9,779,176 (Indirect Direct) | View |
| 2025-11-04 Sale | 2025-11-06 4:23 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $5.21 | $208,400 | 9,859,566 (Indirect Direct) | View |
| 2025-10-23 Sale | 2025-10-24 6:49 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $5.7 | $570,000 | 9,919,566 (Indirect Direct) | View |
| 2025-10-10 Sale | 2025-10-10 6:03 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $6.04 | $604,000 | 10,129,266 (Indirect Direct) | View |
| 2025-09-25 Sale | 2025-09-26 6:32 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.76 | $476,000 | 10,249,266 (Indirect Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:24 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.71 | $471,000 | 10,249,266 (Indirect Direct) | View |
| 2025-08-26 Sale | 2025-08-28 8:00 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $4.84 | $484,000 | 10,369,266 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-16 Tax Withholding | 2026-03-18 5:52 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,075 | $3.42 | 1,180,318 (Direct) | View |
| 2026-03-09 Conversion | 2026-03-11 5:41 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 20,000 | $0 | 9,471,893 (Direct) | View |
| 2026-03-09 Gift | 2026-03-11 5:41 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 20,000 | $0 | 9,471,893 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Hallett David Chief Scientific Officer | 11,908 | $3.49 | 1,097,151 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 27,265 | $3.49 | 9,491,893 (Direct) | View |
| 2026-02-19 Conversion | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $0 | 9,491,893 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $3.49 | 1,195,349 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat CEO and President | 14,280 | $3.49 | 2,290,383 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat CEO and President | 1,703,892 | $0 | 2,304,663 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat CEO and President | 10,364 | $3.98 | 2,304,663 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 470,533 | $0 | 1,220,683 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,400 | $3.98 | 1,220,683 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Hallett David Chief Scientific Officer | 526,318 | $0 | 1,109,059 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Hallett David Chief Scientific Officer | 11,400 | $3.98 | 1,109,059 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-06 5:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 10,364 | $3.56 | 9,559,158 (Direct) | View |
| 2026-02-04 Conversion | 2026-02-06 5:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $0 | 9,559,158 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-06 5:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 30,346 | $0 | 9,559,158 (Direct) | View |
| 2026-01-20 Conversion | 2026-01-22 7:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 40,000 | $0 | 9,579,176 (Direct) | View |
Ownership | 2026-01-09 7:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Hallett David CSO | 0 | $0 | 2,008,807 (Direct) | View |
| 2026-01-05 Conversion | 2026-01-07 5:04 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 60,000 | $0 | 9,619,176 (Direct) | View |
| 2026-01-05 Gift | 2026-01-07 5:04 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Director | 20,000 | $0 | 9,619,176 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 5:47 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 3,571 | $0 | 142,329 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 5:47 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 2,381 | $0 | 3,220,938 (Direct) | View |
| 2025-12-19 Conversion | 2025-12-19 5:04 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 9,679,176 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 6:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.33 | 782,933 (Direct) | View |
| 2025-12-04 Conversion | 2025-12-05 7:20 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 60,000 | $0 | 9,719,176 (Direct) | View |
| 2025-12-04 Gift | 2025-12-05 7:20 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 9,719,176 (Direct) | View |
| 2025-11-25 Tax Withholding | 2025-11-26 5:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 2,271 | $4.03 | 789,990 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $4.14 | 792,261 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 17,584 | $4.14 | 735,538 (Direct) | View |
| 2025-11-19 Conversion | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,000 | $0 | 9,779,176 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 40,390 | $4.14 | 9,779,176 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-06 4:23 pm | N/A 2035-11-05 | RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer | 254,776 | $0 | 922,973 (Direct) | View |
| 2025-11-04 Conversion | 2025-11-06 4:23 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 60,000 | $0 | 9,859,566 (Direct) | View |
| 2025-11-04 Gift | 2025-11-06 4:23 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 9,859,566 (Direct) | View |
| 2025-10-23 Conversion | 2025-10-24 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 9,919,566 (Direct) | View |
| 2025-10-10 Conversion | 2025-10-10 6:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 120,000 | $0 | 10,129,266 (Direct) | View |
| 2025-10-10 Gift | 2025-10-10 6:03 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 10,129,266 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director | 1,961 | $0 | 3,218,557 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director | 2,941 | $0 | 138,758 (Direct) | View |
| 2025-09-25 Conversion | 2025-09-26 6:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 10,249,266 (Direct) | View |
| 2025-09-15 Tax Withholding | 2025-09-17 4:45 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.83 | 804,169 (Direct) | View |
| 2025-09-10 Conversion | 2025-09-12 4:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 120,000 | $0 | 10,249,266 (Direct) | View |
| 2025-09-10 Gift | 2025-09-12 4:24 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 20,000 | $0 | 10,249,266 (Direct) | View |
| 2025-08-26 Conversion | 2025-08-28 8:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer | 100,000 | $0 | 10,369,266 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-19 6:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $5.64 | 811,226 (Direct) | View |